Severity 2 of 5
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Severity 2 (Moderate) recalls cover minor labeling errors, low-risk contamination, and voluntary precautionary recalls. The agency's own classification is typically FDA Class III, or the issue is something like incomplete instructions or a small UPC mismatch where the product itself is safe but doesn't meet documentation requirements. Use the same brand-name product safely; follow the manufacturer's instructions for return or exchange if you want a refund.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
Aidapak Services is recalling Mycophenolate Mofetil capsules that may have been mislabeled as Pramipexole Di-HCl tablets.
Aidapak Services, LLC is recalling Nebivolol HCL 5 mg tablets because they may have been mislabeled as Thyroid or Rasagiline Mesylate.
Aidapak Services, LLC is recalling Levothyroxine Sodium tablets that may have been mislabeled as Omega-3 Fatty Acid capsules.
Aidapak Services, LLC is recalling Sotalol HCL 160 mg tablets that may have been mislabeled as Disulfiram 250 mg.
Aidapak Services, LLC is recalling Phenobarbital 97.2 mg tablets because they may have been mislabeled as 64.8 mg tablets.
Aidapak Services, LLC is recalling Bumetanide 0.5 mg tablets because they may have been mislabeled as Erythromycin DR EC 250 mg.
Aidapak Services, LLC is recalling Nortriptyline HCL capsules because they may have been mislabeled as Rosuvastatin Calcium or Liothyronine Sodium.
Aidapak Services, LLC is recalling Trihexyphenidyl HCL tablets because they may have been mislabeled as Perphenazine tablets.
Aidapak Services, LLC is recalling Nifedipine ER 60 mg tablets because they may have been mislabeled as Nicotine Polacrilex 2 mg lozenges.
Aidapak Services is recalling Pancrelipase DR capsules due to a potential label mixup with Aspirin/ER Dipyridamole. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling azaTHIOprine 50 mg tablets because they may have been mislabeled as Selenium 50 mcg tablets.
Aidapak Services, LLC is recalling Isoniazid 300 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Sennosides tablets because they may have been mislabeled as other medications. The recall covers distribution in four western states.
Aidapak Services, LLC is recalling Nefazodone HCL 200 mg tablets because they may have been mislabeled as 150 mg tablets.
Novartis is recalling NeoCitran and Theraflu cold and sinus powder packets because they may contain foreign substances.
Aidapak Services, LLC is recalling Multivitamin/Multimineral Chew Tablets due to a potential label mixup with Cholecalciferol capsules. The mislabeled products were distributed in four western states.
Aidapak Services is recalling Levothyroxine Sodium tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling CapsuleTOPRIL 25 mg tablets because they may have been mislabeled as Duloxetine HCl DR 20 mg capsules.
Aidapak Services, LLC is recalling Lithium Carbonate ER tablets because they may be mislabeled as Vitamin B Complex Prolonged Release tablets.
Aidapak Services, LLC is recalling Imipramine HCL 25 mg tablets because they may have been mislabeled as Fenofibrate 54 mg.
Novartis Consumer Health is recalling Theraflu Exte powder packets because they may contain foreign substances. The recall covers products distributed in the U.S. and several international markets.
Aidapak Services, LLC is recalling 500 mg Mycophenolate Mofetil tablets because they may be mislabeled as 250 mg capsules.
Aidapak Services is recalling Mycophenolate Mofetil capsules due to a potential label mixup with Calcium Acetate.
Aidapak Services, LLC is recalling 60 mg Thyroid tablets that may have been mislabeled as 30 mg tablets.
Aidapak Services, LLC is recalling Albuterol Sulfate ER 4 mg tablets that may have been mislabeled as Simvastatin 20 mg.